Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BIIB057 in Rheumatoid Arthritis
NCT01652937Phase 2Withdrawn
- Sponsor
- Biogen
- Start
- Aug 2012
- Primary completion
- Feb 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of BIIB057 in rheumatoid arthritis (RA), sponsored by Biogen. Planned start Aug 2012; status: withdrawn.
02
Drugs
BIIB057
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT01652937.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01652937.